Today: 18 November 2025
Subscribe
Browse Category

Medical Breakthroughs News 10 August 2025 - 30 October 2025

Tiny Biotech INTENSITY THERAPEUTICS Stock Skyrockets on Cancer Therapy Breakthrough – Experts See Big Upside

Tiny Biotech INTENSITY THERAPEUTICS Stock Skyrockets on Cancer Therapy Breakthrough – Experts See Big Upside

Stock Rally on Novel Cancer Data Intensity Therapeutics (NASDAQ: INTS) has been one of the market’s biggest movers. On Oct. 30, 2025 its stock was around $0.27 per share investing.com – an 84% drop YTD but up nearly 200% intraday on the news of its Lancet-published trial tipranks.com. Trading volume exploded: ~279 million shares traded on Oct. 30 vs. an average of ~5 M per day tipranks.com. The rally was sparked by the Phase 1/2 study announcement that Intensity’s lead drug, INT230‑6, showed striking tumor control in advanced cancer. The study covered 64 patients across 20+ tumor types – most had failed multiple therapies.
30 October 2025
 ·  ·  ·  ·  · 
Summit Therapeutics (SMMT) Skyrockets on Cancer Breakthrough – Key Facts & Outlook

Summit Therapeutics (SMMT) Skyrockets on Cancer Breakthrough – Key Facts & Outlook

SMMT Stock’s Wild Ride in 2025 Summit Therapeutics’ share price has been on a roller-coaster ride this year. After a steady climb through late summer, SMMT spiked above $25 intraday in mid-October, then pulled back to end last week just under $21 ts2.tech. The stock fell 4.5% on Friday, Oct. 17 alone ts2.tech as traders braced for the upcoming data presentation and earnings call. Even after that dip, Summit shares remain up solidly in 2025 (low double-digit percent gains) – roughly in line with the broader biotech sector (the SPDR S&P Biotech ETF is ~+20% YTD) ts2.tech. These dramatic swings
20 October 2025
 ·  ·  ·  ·  · 
Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer?

Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer?

Stock Price Surge & Recent Performance Achieve Life Sciences stock exploded higher on the FDA news, reflecting growing optimism around cytisinicline’s prospects. In pre-market trading on Oct. 17, ACHV jumped about 22.7% after the company revealed it received a rare FDA Commissioner’s National Priority Voucher (CNPV) for cytisinicline’s vaping cessation indication investing.com. This rally propelled the shares to multi-month highs in the mid-$3 range. Earlier in the week, ACHV had already begun gaining momentum – on Oct. 15 the stock broke above its 200-day moving average (~$2.81) and hit $3.19 marketbeat.com, a bullish technical signal. As of Thursday’s close (Oct.
17 October 2025
 ·  ·  ·  ·  · 
uniQure (QURE) Stock Soars on Huntington’s Breakthrough – Key Facts & 2025 Outlook

A One‑Time Brain Gene Therapy Just Slowed Huntington’s by 75%—Is This the Turning Point Families Have Waited For?

Key facts (quick read) In‑depth report 1) Huntington’s disease, in plain English What it is. HD is a progressive brain disorder that typically begins in mid‑adulthood, causing a mix of movement (chorea, dystonia), cognitive (processing speed, executive function) and psychiatric symptoms (depression, irritability). It is uniformly fatal over years to decades.  NIH Neurological Institute+1 Genetics. HD is autosomal dominant: each child of an affected parent has a 50% chance to inherit the expansion. The disease is caused by CAG repeat expansion in HTT: ≥40 repeats almost always cause disease in a normal lifespan; 36–39 have reduced penetrance; 27–35 are intermediate (no disease in the carrier but potential expansion in offspring). Anticipation—earlier onset in successive generations—occurs, especially with paternal
26 September 2025
 ·  ·  ·  ·  ·  ·  · 
uniQure (QURE) Stock Soars on Huntington’s Breakthrough – Key Facts & 2025 Outlook

Gene Therapy Breakthrough: uniQure’s QURE Stock Skyrockets on Huntington’s Triumph

Stock Performance and Valuation Metrics uniQure’s stock performance in 2025 has been remarkably strong, capped by the explosive move on Sep. 24 after the Huntington’s data release. Prior to the announcement, QURE was trading in the mid-teens (around ~$14–$15) ts2.tech – already up over 100% year-to-date as anticipation for the trial results built. When the pivotal results hit, trading was halted pre-market due to pending news ts2.tech. Once the halt lifted, the stock opened dramatically higher and at one point reached the mid-$40s per share, up nearly 160–200% in a single session pharmaphorum.com. It eventually closed with a gain of around 150%+ on the day investing.com. This massive one-day jump is one
24 September 2025
 ·  ·  ·  ·  · 
Glowing Planets, Seaweed Invasions & “Sleeper” Cancer Cures: Top Science Breakthroughs (Sept 2–3, 2025)

Glowing Planets, Seaweed Invasions & “Sleeper” Cancer Cures: Top Science Breakthroughs (Sept 2–3, 2025)

Space & Astronomy Baby Planet Caught in the Act: A landmark discovery in astronomy came from an international team that directly imaged a newborn exoplanet still in the process of formation. The planet, dubbed WISPIT 2b, is a gas giant roughly 5 million years old located around a young Sun-like star scitechdaily.com. Observations with ESO’s Very Large Telescope in Chile revealed WISPIT 2b as a faint dot within a multi-ringed protoplanetary disk of dust and gas ts2.tech scitechdaily.com. This makes WISPIT 2b the first unambiguous photo of a planet forming inside a ringed disk – essentially a baby planet still glowing from its
3 September 2025
 ·  ·  ·  · 
COVID Booster Shocker, Pharma Mega-Deals & Alzheimer’s Breakthroughs – Global Health Roundup (Aug 28–29, 2025)

COVID Booster Shocker, Pharma Mega-Deals & Alzheimer’s Breakthroughs – Global Health Roundup (Aug 28–29, 2025)

Drug Approvals & Clinical Trial Results Updated COVID Boosters Get Narrow Nod: The U.S. FDA approved new fall COVID-19 booster shots from Pfizer/BioNTech and Moderna on August 27 – but with strict eligibility limits. Only adults 65+ and younger people with certain medical conditions are cleared for the updated vaccines, and emergency use authorizations for routine use in healthy children were removed realeconomy.rsmus.com. Health experts immediately sounded alarms: the Infectious Diseases Society of America blasted the “narrowed” booster rollout as contrary to scientific guidance and a risk to lives cidrap.umn.edu. They warn these restrictions could hinder access, especially for children,
29 August 2025
 ·  ·  ·  ·  ·  ·  ·  ·  · 
Starship Soars, Pig Lung Transplant Breakthrough, and Heatwaves Speed Aging – Science’s Latest Shocks

Starship Soars, Pig Lung Transplant Breakthrough, and Heatwaves Speed Aging – Science’s Latest Shocks

Space: Starship’s Milestone and Asteroid Secrets SpaceX’s Starship rocket finally broke its streak of setbacks with a successful integrated test flight on August 26. The 120-meter behemoth lifted off from Starbase, Texas and reached space on its 10th test, deploying eight dummy Starlink satellites from its new “Pez dispenser” mechanism reuters.com. It then survived a blazing reentry in Earth’s atmosphere – a key trial of its heat shield tiles – before performing a controlled engine-guided splashdown in the ocean reuters.com reuters.com. This marks Starship’s first full mission success after several explosive attempts. SpaceX CEO Elon Musk emphasized that many challenges
27 August 2025
 ·  ·  ·  ·  · 
Breakthrough Cures, Billion-Dollar Bets & Health Shockers – Global Biotech & Health News Roundup (Aug 23–24, 2025)

Breakthrough Cures, Billion-Dollar Bets & Health Shockers – Global Biotech & Health News Roundup (Aug 23–24, 2025)

Regulatory Approvals & Clinical Milestones Pharma & Biotech Industry Moves Startups & Innovation Highlights ([…Placeholder – if needed, otherwise this section can be omitted due to a lack of specific startup news on Aug 23–24 beyond the AI deal covered above.]) (The content above demonstrates how startup news might be presented. If no significant startup news occurred on Aug 23–24 beyond what’s covered in other sections, this section can be brief or omitted.) Medical Research & Innovation Public Health & Policy Developments Sources: FDA and company announcements via Reuters reuters.com reuters.com reuters.com reuters.com; FiercePharma and Reuters on industry moves reuters.com
24 August 2025
 ·  ·  ·  ·  ·  ·  ·  · 
Breakthrough Cures, Big Deals, and Global Health Alerts – Biotech & Health News Roundup (Aug 16–17, 2025)

Breakthrough Cures, Big Deals, and Global Health Alerts – Biotech & Health News Roundup (Aug 16–17, 2025)

For the period August 16–17, 2025, the biotech, pharma, medical, and health sectors saw a range of significant developments worldwide. Below is a comprehensive roundup of top stories categorized by theme, complete with expert insights and source links: Clinical Trial Results & Study Readouts Drug & Device Approvals Mergers, Acquisitions & Partnerships Public Health Alerts Research & Medical Breakthroughs Healthcare Policy & Industry Trends Each news item above includes direct source references for verification. This roundup spans clinical trial outcomes, drug approvals, industry deals, public health alerts, research breakthroughs, and policy updates from around the globe during August 16–17, 2025,
17 August 2025
 ·  ·  ·  · 
Memory Loss Reversed, ‘Coral’ on Mars, and a Tiny Killer Whale: Science News Roundup (Aug 12–13, 2025)

Memory Loss Reversed, ‘Coral’ on Mars, and a Tiny Killer Whale: Science News Roundup (Aug 12–13, 2025)

On its 4,608th Martian sol, NASA’s Curiosity rover captured a 5-cm coral-shaped rock nicknamed Paposo in Gale Crater, suggesting ancient liquid water in Mars’ history. A global river study radiocarbon-dating CO2 from over 700 rivers found that about 60% of river-emitted carbon comes from ancient carbon stores. The same study estimates plants and soils may be absorbing roughly 1 gigaton of CO2 per year to offset these ancient carbon releases. By 2080, rising seas could inundate Easter Island’s Moai at Ahu Tongariki and up to 51 other cultural sites, risking UNESCO World Heritage status. Janjucetus dullardi, a 2-meter-long, sharp-toothed Oligocene
13 August 2025
 ·  ·  ·  · 
Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

Researchers in China unveiled a hydrogel-based “smart” wound dressing that speeds diabetic ulcer healing, with a single application achieving about 90% wound closure in 12 days by delivering microRNA-loaded vesicles that suppress the vessel-growth inhibitor TSP-1. A Swedish study published August 8 identified 87 DNA methylation sites in blood from 752 newly diagnosed diabetics followed for seven years, creating a score that predicted cardiovascular outcomes with 96% accuracy for identifying low-risk patients. A natural compound in maple tree syrup, epicatechin gallate (ECG), blocked Streptococcus mutans biofilm formation in lab tests, suggesting potential as a safe plaque-preventing agent in mouthwash or
10 August 2025
 ·  ·  ·  · 
1 2
Go toTop